DeName Bridger, Divine Holly, Nicholas Amy, Steinke Douglas T, Johnson Carrie L
College of Pharmacy, Kroger Pharmacy, Lexington, KY 40536-0284, USA.
J Am Pharm Assoc (2003). 2008 Nov-Dec;48(6):731-6. doi: 10.1331/JAPhA.2008.07070.
To evaluate the efficacy of pharmacist recommendations to health care providers, as part of PharmacistCARE, a single-center, pharmacist-run, diabetes medication therapy management (MTM) service. If the recommendation was accepted, a secondary objective was to measure the length of time for acceptance.
Prospective assessment.
University of Kentucky (UK), from March 2003 through December 2006.
172 adult patients with diabetes enrolled in the UK Health Plan who participated in the DiabetesCARE program.
Pharmacists provided medication therapy-related recommendations to health care providers.
Acceptance of pharmacist recommendations by health care providers, length of time to acceptance, and cost savings attained with formulary recommendations.
A total of 692 recommendations were sent to health care providers; 425 (61.4%) were accepted. A total of 578 clinical recommendations were related to drug therapy problems; 348 (60.2%) were accepted by health care providers. Median time to acceptance for clinical recommendations was 13.5 days (0-229). Formulary recommendations accounted for 114 (16%) of the total recommendations, 77 (67.5%) were accepted, and median time to acceptance was 47.2 days (0-172). Average monthly cost savings per accepted formulary recommendation was $13.59 for the health plan and $13.85 for the patient.
A similar percentage of health care provider acceptance (61.4%) was seen compared with previous studies of pharmacists' interventions in different practice settings. To our knowledge, this is the first study to evaluate time to acceptance of pharmacist recommendations to health care providers, including the resolutions made through collaborative drug therapy management. Lastly, the current study reinforces the assertion that pharmacists can positively affect cost savings for both the patient and health plan, through formulary management.
评估药剂师向医疗服务提供者提出的建议的有效性，这是一项单中心、由药剂师主导的糖尿病药物治疗管理（MTM）服务PharmacistCARE的一部分。如果建议被接受，第二个目标是衡量接受所需的时间长度。
前瞻性评估。
肯塔基大学（UK），时间从2003年3月至2006年12月。
172名参加UK健康计划并参与DiabetesCARE项目的成年糖尿病患者。
药剂师向医疗服务提供者提供与药物治疗相关的建议。
医疗服务提供者对药剂师建议的接受情况、接受所需时间长度以及通过处方集建议实现的成本节约。
共向医疗服务提供者发送了692条建议；425条（61.4%）被接受。共有578条临床建议与药物治疗问题相关；348条（60.2%）被医疗服务提供者接受。临床建议接受的中位时间为13.5天（0 - 229天）。处方集建议占总建议的114条（16%），77条（67.5%）被接受，接受的中位时间为47.2天（0 - 172天）。对于健康计划而言，每条被接受的处方集建议平均每月节省成本13.59美元，对患者而言为13.85美元。
与之前在不同实践环境中对药剂师干预的研究相比，医疗服务提供者的接受比例（61.4%）相似。据我们所知，这是第一项评估医疗服务提供者接受药剂师建议所需时间的研究，包括通过药物联合治疗管理做出的决策。最后，当前研究强化了这样一种观点，即药剂师可以通过处方集管理对患者和健康计划的成本节约产生积极影响。
